High-Throughput Biological Assay Development

The contract seeks the development of high-throughput biological assays designed for scalability and reproducibility, with a specific focus on integration with autonomous systems. The work will prioritize applications in drug screening and gene editing, requiring innovative approaches to automate and standardize complex biological processes. Emphasis is placed on creating assay platforms that can function reliably within robotic and AI-driven environments, ensuring consistent data output and minimal human intervention across large-scale operations. The technical challenge revolves around optimizing assay conditions for robustness, sensitivity, and compatibility with high-volume throughput while maintaining biological relevance. Submitted proposals must align with the NAICS code 541990, indicating a focus on scientific research and development services. The opportunity is structured as a subcontract under the Defense Advanced Research Projects Agency, part of the Department of Defense, with a submission deadline of July 22, 2026. There is no set-aside designation, and performance location details are unspecified, suggesting flexibility in where the work may be conducted. The solicitation is open to qualified entities capable of delivering advanced biological assay technologies that meet stringent autonomy and reproducibility criteria, with no point of contact provided through the public portal.